Literature DB >> 22245924

Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.

Yoshihiro Kakeji1, Manabu Yamamoto, Shuhei Ito, Masahiko Sugiyama, Akinori Egashira, Hiroshi Saeki, Masaru Morita, Yoshihisa Sakaguchi, Yasushi Toh, Yoshihiko Maehara.   

Abstract

PURPOSE: Both squamous cell carcinomas and adenocarcinomas can develop in the esophagogastric junction. To clarify the appropriate lymph node dissection range, lymph node metastases from cancers in the esophagogastric junction were investigated.
METHODS: The nodal metastases were analyzed in 64 patients with squamous cell carcinoma and 129 with adenocarcinoma according to Siewert's classification, which is based on topographic anatomical criteria for adenocarcinoma.
RESULTS: The squamous cell carcinomas located above the esophagocardial junction had more frequent metastasis to the lower and middle mediastinal lymph nodes in proportion to the depth of the tumor. Nodal metastasis was also often detected in the abdominal lymph nodes. In contrast, adenocarcinomas metastasized less frequently to the mediastinal lymph nodes, and the metastatic rates in the abdominal nodes were higher than those from squamous cell carcinoma.
CONCLUSION: Esophagectomy with mediastinal and abdominal lymph node dissection is considered to be an appropriate approach for surgical resection of squamous cell carcinomas, whereas transhiatally extended gastrectomy with lower mediastinal and abdominal lymph node dissection is recommended for the treatment of adenocarcinomas.

Entities:  

Mesh:

Year:  2012        PMID: 22245924     DOI: 10.1007/s00595-011-0114-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer.

Authors:  K Kitamura; S Nishida; D Ichikawa; H Taniguchi; A Hagiwara; T Yamaguchi; K Sawai
Journal:  Br J Surg       Date:  1999-01       Impact factor: 6.939

Review 2.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

Review 3.  Epidemiology of esophageal adenocarcinoma.

Authors:  Manuel Pera; Carlos Manterola; Oscar Vidal; Luis Grande
Journal:  J Surg Oncol       Date:  2005-12-01       Impact factor: 3.454

4.  Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma.

Authors:  Y Kodera; Y Yamamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  World J Surg       Date:  1997 Jul-Aug       Impact factor: 3.352

5.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.

Authors:  Heiko Pohl; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

6.  Multimodal treatment of gastrointestinal tract tumors: consequences for surgery.

Authors:  J Rüdiger Siewert; Hubert J Stein; Burkhard H A von Rahden
Journal:  World J Surg       Date:  2005-08       Impact factor: 3.352

Review 7.  Surgical management of esophagogastric junction tumors.

Authors:  Burkhard H A von Rahden; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Lymph node metastases in cancer of the thoracic esophagus.

Authors:  Y Sannohe; R Hiratsuka; K Doki
Journal:  Am J Surg       Date:  1981-02       Impact factor: 2.565

9.  Adenocarcinoma of the esophagogastric junction in Japan.

Authors:  Manabu Yamamoto; Hideo Baba; Akinori Egashira; Eiji Oki; Masahiko Ikebe; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Hepatogastroenterology       Date:  2008 Jan-Feb

10.  Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  S Ohno; S Tomisaki; H Oiwa; Y Sakaguchi; Y Ichiyoshi; Y Maehara; K Sugimachi
Journal:  J Am Coll Surg       Date:  1995-05       Impact factor: 6.113

View more
  13 in total

1.  Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.

Authors:  Hiroyuki Yamada; Masao Hosokawa; Kazuo Itoh; Toshinao Takenouchi; Yoshihiro Kinoshita; Tomohiro Kikkawa; Keita Sakashita; Shion Uemura; Yasunori Nishida; Takaya Kusumi; Shigeyuki Sasaki
Journal:  Surg Today       Date:  2014-07       Impact factor: 2.549

2.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

3.  Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Authors:  Susanne Blank; Thomas Schmidt; Patrick Heger; Moritz J Strowitzki; Leila Sisic; Ulrike Heger; Henrik Nienhueser; Georg Martin Haag; Thomas Bruckner; André L Mihaljevic; Katja Ott; Markus W Büchler; Alexis Ulrich
Journal:  Gastric Cancer       Date:  2017-07-06       Impact factor: 7.370

4.  Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction.

Authors:  Takaki Yoshikawa; Hiroya Takeuchi; Shinichi Hasegawa; Isao Nozaki; Kentaro Kishi; Seiji Ito; Masaki Ohi; Shinji Mine; Johji Hara; Tatsuo Matsuda; Naoki Hiki; Yukinori Kurokawa
Journal:  Gastric Cancer       Date:  2014-11-21       Impact factor: 7.370

Review 5.  Siewert III adenocarcinoma: treatment update.

Authors:  Alberto Di Leo; Andrea Zanoni
Journal:  Updates Surg       Date:  2017-03-16

6.  The Role of No. 10 Lymphadenectomy for Advanced Proximal Gastric Cancer Patients Without Metastasis to No. 4sa and No. 4sb Lymph Nodes.

Authors:  Shibo Bian; Hongqing Xi; Xiaosong Wu; Jianxin Cui; Liangang Ma; Rong Chen; Bo Wei; Lin Chen
Journal:  J Gastrointest Surg       Date:  2016-03-03       Impact factor: 3.452

7.  The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.

Authors:  Hironobu Goto; Masanori Tokunaga; Yuichiro Miki; Rie Makuuchi; Norihiko Sugisawa; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masahiro Niihara; Yasuhiro Tsubosa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2014-03-22       Impact factor: 7.370

8.  Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China.

Authors:  Baoyu Zhao; Zhenzhan Zhang; Debin Mo; Yiming Lu; Yanfeng Hu; Jiang Yu; Hao Liu; Guoxin Li
Journal:  Front Oncol       Date:  2019-01-21       Impact factor: 6.244

9.  Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study.

Authors:  Hiroaki Ito; Haruhiro Inoue; Noriko Odaka; Hitoshi Satodate; Michitaka Suzuki; Shumpei Mukai; Yusuke Takehara; Hiroyuki Kida; Shin-Ei Kudo
Journal:  J Exp Clin Cancer Res       Date:  2013-01-07

10.  Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.

Authors:  Chen-Bin Lv; Chang-Ming Huang; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.